Tesla's Challenges: Navigating Uncertain Momentum
July 11, 2025 The Harsh Truth: Saving Won’t Make You Rich
July 10, 2025 Moving Out of State from Rockville? Start Here
July 10, 2025 Drive Like Royalty: Best Exotic Cars to Rent in Monaco in 2025
July 10, 2025 2025 Altseason: The Next Frontier in Crypto Growth
July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?
Charles River Laboratories International (CRL) stock forecast for 2025
Updated: June 2, 2025 (14:52)
Sector: HealthcareThe share price of Charles River Laboratories International, Inc. (CRL) now
50/200 Day Moving Average: $132.19 / $172.45
This figure corresponds to the Average Price over the previous 50/200 days. For Charles River Laboratories International stocks, the 50-day moving average is the resistance level today.
For Charles River Laboratories International stocks, the 200-day moving average is the resistance level today.
Are you interested in Charles River Laboratories International, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Charles River Laboratories International stock price in 2025. How much will one Charles River Laboratories International share be worth in 2025? Is it worth taking profit / loss on CRL stock now or waiting? What are analysts' forecasts for Charles River Laboratories International stock?
We forecast Charles River Laboratories International stock performance using neural networks based on historical data on CRL stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Charles River Laboratories International, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Charles River Laboratories International analysts is $158.94. Today 200 Day Moving Average is the resistance level (172.45 $). 50 Day Moving Average is the resistance level (132.19 $).
Historical and forecast chart of Charles River Laboratories International, Inc. stock
The chart below shows the historical price of Charles River Laboratories International stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRL stock price can be found in the table below.
Charles River Laboratories International, Inc., an early stage contract research company, provides drug discovery, non-clinical development and safety testing services in the United States, Europe, Canada, Asia Pacific and worldwide. It operates across three segments: Research Models and Services (RMS), Security Discovery and Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment manufactures and markets lines of research models and specially bred rats and mice for use by researchers.
Charles River Laboratories International (CRL) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul | 136.39 | 127.03 | 144.98 | 12.38 % |
| Aug | 143.07 | 134.06 | 151.29 | 11.39 % |
| Sep | 135.66 | 123.89 | 141.17 | 12.24 % |
| Oct | 136.99 | 131.81 | 150.22 | 12.26 % |
| Nov | 145.24 | 141.17 | 157.44 | 10.33 % |
| Dec | 148.08 | 143.94 | 156.59 | 8.08 % |
Charles River Laboratories International information and performance
251 BALLARDVALE ST, WILMINGTON, MA, US
Market capitalization of the Charles River Laboratories International, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRL shares in the company outstanding by the market price of one share.
EBITDA of Charles River Laboratories International is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Charles River Laboratories International price target for 2025 by month
Target values for the price of one Charles River Laboratories International share for Jul 2025.
In Jul, the Positive dynamics for Charles River Laboratories International, Inc. shares will prevail with possible monthly volatility of 12.380% volatility is expected.
Pessimistic target level: 127.03
Optimistic target level: 144.98
Target values for the price of one Charles River Laboratories International share for Aug 2025.
In Aug, the Positive dynamics for Charles River Laboratories International, Inc. shares will prevail with possible monthly volatility of 11.386% volatility is expected.
Pessimistic target level: 134.06
Optimistic target level: 151.29
Target values for the price of one Charles River Laboratories International share for Sep 2025.
In Sep, the Negative dynamics for Charles River Laboratories International, Inc. shares will prevail with possible monthly volatility of 12.243% volatility is expected.
Pessimistic target level: 123.89
Optimistic target level: 141.17
Target values for the price of one Charles River Laboratories International share for Oct 2025.
In Oct, the Positive dynamics for Charles River Laboratories International, Inc. shares will prevail with possible monthly volatility of 12.256% volatility is expected.
Pessimistic target level: 131.81
Optimistic target level: 150.22
Target values for the price of one Charles River Laboratories International share for Nov 2025.
In Nov, the Positive dynamics for Charles River Laboratories International, Inc. shares will prevail with possible monthly volatility of 10.332% volatility is expected.
Pessimistic target level: 141.17
Optimistic target level: 157.44
Target values for the price of one Charles River Laboratories International share for Dec 2025.
In Dec, the Positive dynamics for Charles River Laboratories International, Inc. shares will prevail with possible monthly volatility of 8.077% volatility is expected.
Pessimistic target level: 143.94
Optimistic target level: 156.59
